Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acceleron Pharma Inc (NASDAQ:XLRN)

37.31
Delayed Data
As of 3:59pm ET
 -1.89 / -4.82%
Today’s Change
23.07
Today|||52-Week Range
41.69
+46.20%
Year-to-Date

Today’s Trading

Previous close39.20
Today’s open38.97
Day’s range36.75 - 39.23
Volume615,068
Average volume (3 months)413,723
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+20.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+53.46%
P/E ratioNM
Price/Sales34.40
Price/Book6.65

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+1.38+3.99%
MNTAMomenta Pharmaceutic...-0.15-1.05%
HALOHalozyme Therapeutic...+0.05+0.28%
SGMOSangamo Therapeutics...-0.20-1.41%
Data as of 4:00pm ET, 10/19/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$27.8M
Annual profit (last year)-$57.0M
Net profit margin-205.30%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Habib J. Dable
Chief Financial Officer, Treasurer &
Senior VP
Kevin F. McLaughlin
Corporate headquarters
Cambridge, Massachusetts

Forecasts